Fortress Biotech Inc FBIO:NASDAQ

Last Price$0.92Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 1/30/23
Cboe Real-Time Quotes
Today's Change-0.008(0.90%)
Bid (Size)$0.92 (100)
Ask (Size)$0.93 (1,500)
Day Low / High$0.90 - 0.93
Volume101.7 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/30/2023


Fortress Biotech Inc ( NASDAQ )

Price: $0.92
Change: -0.008 (0.90%)
Volume: 101.7 K
3:59PM ET 1/30/2023

Atossa Therapeutics Inc ( NASDAQ )

Price: $0.80
Change: +0.0007 (0.09%)
Volume: 147.0 K
10:11AM ET 1/31/2023

Beyondspring Inc ( NASDAQ )

Price: $2.67
Change: +0.12 (4.71%)
Volume: 110.2 K
11:04AM ET 1/31/2023

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Dare Bioscience Inc ( NASDAQ )

Price: $1.27
Change: +0.02 (2.01%)
Volume: 89.4 K
10:35AM ET 1/31/2023

Read more news Recent News

Fortress Biotech Unit Expands Gout Drug License Deal With Fuji Yakuhin to Include New Markets
11:03AM ET 12/14/2022 MT Newswires

Fortress Biotech (FBIO) subsidiary Urica Therapeutics said Wednesday it has expanded its gout drug development license agreement with Fuji Yakuhin to...

Fortress Biotech Swings to Q3 Non-GAAP Loss, Revenue Drops
4:38PM ET 11/14/2022 MT Newswires

Fortress Biotech (FBIO) reported Monday a Q3 non-GAAP loss of $0.08 per share, compared with earnings of $0.60 per share a year earlier. One analyst...

-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.5M
4:09PM ET 11/14/2022 MT Newswires


-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.1M
4:08PM ET 11/14/2022 MT Newswires


Company Profile

Business DescriptionFortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL. View company web site for more details
Address1111 Kane Concourse
Bay Harbor Islands, Florida 33154
Number of Employees88
Recent SEC Filing01/13/2023SC 13D/A
Chairman, President & Chief Executive OfficerLindsay Allan Rosenwald
CFO & Head-Corporate DevelopmentDavid Jin
Senior Vice President-Biologics OperationsGeorge C. Avgerinos
Director & Vice Chairman-Strategic DevelopmentMichael Sean Weiss

Company Highlights

Price Open$0.90
Previous Close$0.93
52 Week Range$0.48 - 2.16
Market Capitalization$99.3 M
Shares Outstanding107.7 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement03/27/2023

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.98
Beta vs. S&P 500N/A
Revenue$26.9 M
Net Profit Margin-117.49%
Return on Equity-105.60%

Analyst Ratings as of 01/24/2023

Consensus RecommendationConsensus Icon
Powered by Factset